Macrophage-Derived LCN2 Promotes Methamphetamine-Induced Pulmonary Hypertension

Jie Zhou1, Zhenzhen Xu1, Dao-Bo Peng2

  • 1Guangzhou Key Laboratory of Forensic Multi-Omics for Precision Identification, School of Forensic Medicine, Southern Medical University, P.R. China (J.Z., Z.X., X.L., S.C., K.D., Y.J., C.G., X.P., W.-B.X.).

Summary

Lipocalin 2 (LCN2) plays a key role in methamphetamine-induced pulmonary hypertension (METH-PH). LCN2 deficiency protects against METH-PH by reducing inflammation and vascular remodeling, suggesting LCN2 as a therapeutic target.

Related Concept Videos